Skip to main content
SpringerLink
Log in

Current epidemiology and practice patterns in prevention and treatment of PD-related infections in Poland

  • Nephrology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Background

Peritoneal dialysis (PD) related infections are associated with technique failure and mortality. The aim of this multicentre study was to examine epidemiology, treatment and outcomes of PD-related infections in Poland as well as practice patterns for prevention of these complications in the context of current ISPD recommendations.

Methods

A survey on PD practices in relation to infectious complications was conducted in 11 large Polish PD centres. Epidemiology of peritonitis and exit-site infections (ESI) was examined in all patients treated in these units over a 2 year period.

Results

The study included data on 559 PD patients with 62.4% on CAPD. Practice patterns for prevention of infectious complications are presented. The rate of peritonitis was 0.29 episodes per year at risk, with Gram positive microorganisms responsible for more than 50% of infections and 85.8% effectively treated. Diagnosis and treatment followed ISPD guidelines however most units did not provide an anti-fungal prophylaxis. Although neither of the centres reported routine topical mupirocin on catheter exit-site, the rate of ESI was low (0.1 episodes per year at risk), with Staphylococcus aureus as most common pathogen and full recovery in 78.3% of cases.

Conclusion

The study shows rewarding outcomes in prevention and treatment of PD-associated infections, mainly due to a thorough compliance with the current ISPD guidelines, although some deviations from the recommendations in terms of practice patterns have been observed. More studies are needed in large numbers of patients to differentiate the importance of specific recommendations and further support the guidelines.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Li PK, Szeto CC, Piraino B et al (2016) ISPD peritonitis recommendations: 2016 update on prevention and treatment. Perit Dial Int 36(5):481–508

    Article  Google Scholar 

  2. Szeto CC, Li PK, Johnson DW et al (2017) ISPD catheter-related infection recommendations: 2017 update. Perit Dial Int 37(2):141–154

    Article  Google Scholar 

  3. Chow KM, Szeto CC, Leung CB et al (2005) A risk analysis of continuous ambulatory peritoneal dialysis-related peritonitis. Perit Dial Int 25(4):374–379

    PubMed  Google Scholar 

  4. De Vecchi AF, Maccario M, Braga M et al (1998) Peritoneal dialysis in nondiabetic patients older than 70 years: comparison with patients aged 40 to 60 years. Am J Kidney Dis 31(3):479–490

    Article  Google Scholar 

  5. Lobo JV, Villar KR, de Andrade Junior MP, Bastos Kde A (2010) Predictor factors of peritoneal dialysis-related peritonitis. J Bras Nefrol 32(2):156–164

    Article  Google Scholar 

  6. Kotsanas D, Polkinghorne KR, Korman TM, Atkins RC, Brown F (2007) Risk factors for peritoneal dialysis-related peritonitis: can we reduce the incidence and improve patient selection?. Nephrology 12(3):239–245

    Article  Google Scholar 

  7. Oo TN, Roberts TL, Collins AJ (2005) A comparison of peritonitis rates from the United States Renal Data System database: CAPD versus continuous cycling peritoneal dialysis patients. Am J Kidney Dis 45(2):372–380

    Article  Google Scholar 

  8. Lim WH, Boudville N, McDonald SP et al (2011) Remote indigenous peritoneal dialysis patients have higher risk of peritonitis, technique failure, all-cause and peritonitis-related mortality. Nephrol Dial Transplant 26(10):3366–3372

    Article  Google Scholar 

  9. Geerlings SE, Hoepelman AI (1999) Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 26(3–4):259–265

    Article  CAS  Google Scholar 

  10. Han SH, Lee SC, Ahn SV et al (2007) Reduced residual renal function is a risk of peritonitis in continuous ambulatory peritoneal dialysis patients. Nephrol Dial Transplant 22(9):2653–2658

    Article  Google Scholar 

  11. Zent R, Myers JE, Donald D, Rayner BL (1994) Continuous ambulatory peritoneal dialysis: an option in the developing world? Perit Dial Int 14(1):48–51

    CAS  PubMed  Google Scholar 

  12. Toda S, Ito Y, Mizuno M et al (2012) Asymptomatic diverticulosis identified by computed tomography is not a risk factor for enteric peritonitis. Nephrol Dial Transplant 27(6):2511–2516

    Article  Google Scholar 

  13. Tranaeus A, Heimburger O, Granqvist S (1990) Diverticular disease of the colon: a risk factor for peritonitis in continuous peritoneal dialysis. Nephrol Dial Transplant 5(2):141–147

    Article  CAS  Google Scholar 

  14. Zhang L, Hawley CM, Johnson DW (2016) Focus on peritoneal dialysis training: working to decrease peritonitis rates. Nephrol Dial Transplant 31(2):214–222

    PubMed  Google Scholar 

  15. Piraino B, Bernardini J, Brown E et al (2011) ISPD position statement on reducing the risks of peritoneal dialysis-related infections. Perit Dial Int 31(6):614–630

    Article  CAS  Google Scholar 

  16. Bernardini J, Price V, Figueiredo A (2006) International society for peritoneal dialysis nursing liaison C: peritoneal dialysis patient training, 2006. Perit Dial Int 26(6):625–632

    PubMed  Google Scholar 

  17. Dong J, Chen Y (2010) Impact of the bag exchange procedure on risk of peritonitis. Perit Dial Int 30(4):440–447

    Article  Google Scholar 

  18. Bernardini J, Nagy M, Piraino B (2000) Pattern of noncompliance with dialysis exchanges in peritoneal dialysis patients. Am J Kidney Dis 35(6):1104–1110

    Article  CAS  Google Scholar 

  19. Strippoli GF, Tong A, Johnson D, Schena FP, Craig JC (2004) Antimicrobial agents to prevent peritonitis in peritoneal dialysis: a systematic review of randomized controlled trials. Am J Kidney Dis 44(4):591–603

    Article  CAS  Google Scholar 

  20. Kofteridis DP, Valachis A, Perakis K et al (2010) Peritoneal dialysis-associated peritonitis: clinical features and predictors of outcome. Int J Infect Dis 14(6):e489–e493

    Article  Google Scholar 

  21. Ghali JR, Bannister KM, Brown FG et al (2011) Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients. Perit Dial Int 31(6):651–662

    Article  Google Scholar 

  22. Zelenitsky SA, Howarth J, Lagace-Wiens P et al (2017) Microbiological trends and antimicrobial resistance in peritoneal dialysis-related peritonitis, 2005–2014. Perit Dial Int 37(2):170–176

    Article  CAS  Google Scholar 

  23. Campbell DJ, Mudge DW, Gallagher MP et al (2017) Infection prophylaxis in peritoneal dialysis patients: results from an Australia/New Zealand survey. Perit Dial Int 37(2):191–197

    Article  CAS  Google Scholar 

  24. Williams PF, Moncrieff N, Marriott J (2000) No benefit in using nystatin prophylaxis against fungal peritonitis in peritoneal dialysis patients. Perit Dial Int 20(3):352–353

    CAS  PubMed  Google Scholar 

  25. Perl J, Zhao J, Bieber B et al (2016) Variation in the treatment and prevention of peritoneal dialysis related infections: preliminary results from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS). Nephrol Dial Transplant 31(Supplement 1):i235–i245

    Google Scholar 

  26. Htay H, Johnson DW, Wu SY et al (2017) Comparison of topical chlorhexidine and mupirocin for the prevention of Exit-site infection in incident peritoneal dialysis patients. Perit Dial Int 37(3):266–272

    Article  Google Scholar 

  27. Thodis E, Bhaskaran S, Pasadakis P et al (1998) Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site. Perit Dial Int 18(3):261–270

    CAS  PubMed  Google Scholar 

  28. Lim CT, Wong KS, Foo MW (2005) The impact of topical mupirocin on peritoneal dialysis infection in Singapore General Hospital. Nephrol Dial Transplant 20(10):2202–2206

    Article  CAS  Google Scholar 

  29. Kopriva-Altfahrt G, Konig P, Mundle M et al (2009) Exit-site care in Austrian peritoneal dialysis centers—a nationwide survey. Perit Dial Int 29(3):330–339

    PubMed  Google Scholar 

  30. Bechade C, Guillouet S, Verger C et al (2017) Centre characteristics associated with the risk of peritonitis in peritoneal dialysis: a hierarchical modelling approach based on the data of the French Language Peritoneal Dialysis Registry. Nephrol Dial Transplant 32(6):1018–1023

    Article  Google Scholar 

  31. Nadeau-Fredette AC, Johnson DW, Hawley CM et al (2016) Center-specific factors associated with peritonitis risk-a multi-center registry analysis. Perit Dial Int 36(5):509–518

    Article  Google Scholar 

  32. Htay H, Cho Y, Pascoe EM et al (2018) Center effects and peritoneal dialysis peritonitis outcomes: analysis of a national registry. Am J Kidney Dis 71(6):814–821

    Article  Google Scholar 

  33. Perl J, Davies SJ, Lambie M et al (2016) The Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS): unifying efforts to inform practice and improve global outcomes in peritoneal dialysis. Perit Dial Int 36(3):297–307

    Article  Google Scholar 

Download references

Funding

There was no funding to the study.

Author information

Authors and Affiliations

  1. Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdańsk, Gdańsk, Poland

    Monika Lichodziejewska-Niemierko & Michał Chmielewski

  2. Department of Nephrology, Dialysis and Internal Diseases, Medical University of Warsaw, Warsaw, Poland

    Ewa Wojtaszek & Joanna Matuszkiewicz-Rowińska

  3. 1st Department of Nephrology and Transplantation with Dialysis Unit, Medical University of Białystok, Białystok, Poland

    Ewa Suchowierska & Beata Naumnik

  4. Department of Nephrology, Transplantology and Internal Medicine, Pomeranian Medical University, Szczecin, Poland

    Edyta Gołembiewska

  5. Department of Nephrology, Hypertension and Internal Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Bydgoszcz, Poland

    Magdalena Grajewska & Beata Sulikowska

  6. Department of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine, Warsaw, Poland

    Stanisław Niemczyk & Magdalena Mosakowska

  7. Department of Nephrology and Transplantation Medicine, Wrocław Medical University, Wrocław, Poland

    Renata Kłak

  8. Dialysis Unit, Fresenius Nephrocare, Kraków, Poland

    Bernadeta Marcykiewicz

  9. Dialysis Unit, Fresenius Nephrocare, Sieradz, Poland

    Krzysztof Kalita

  10. Dialysis Unit, Fresenius Nephrocare, Ostrów Wielkopolski, Poland

    Robert Krawczyk & Krzysztof Cieszyński

  11. Dialysis Unit, Fresenius Nephrocare, Zabrze, Poland

    Mirosław Adamski

  12. Clinical Microbiology Laboratory, University Hospital of Gdańsk, Gdańsk, Poland

    Marek Bronk

  13. Dialysis Unit, Fresenius Nephrocare, Gdańsk, Poland

    Monika Lichodziejewska-Niemierko & Piotr Jagodziński

Authors
  1. Monika Lichodziejewska-Niemierko
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michał Chmielewski
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ewa Wojtaszek
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ewa Suchowierska
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Edyta Gołembiewska
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Magdalena Grajewska
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Joanna Matuszkiewicz-Rowińska
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Beata Naumnik
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Beata Sulikowska
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Stanisław Niemczyk
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Renata Kłak
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Magdalena Mosakowska
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Piotr Jagodziński
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Bernadeta Marcykiewicz
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Krzysztof Kalita
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Robert Krawczyk
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Krzysztof Cieszyński
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Mirosław Adamski
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Marek Bronk
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Monika Lichodziejewska-Niemierko.

Ethics declarations

Conflict of interest

MLN,JMR,EG,BS,MG,PJ - Speaker’s honoraria from Fresenius Medical Care, MLN,MC,BN,EG,BS,EW,ES,MG,RK- Speaker’s honoraria from Baxter, BN,BS - Speaker’s honoraria from MSD, BN - Speaker’s honoraria from Amgen, JMR, BN,BS - Speaker’s honoraria from Roche, BS - Speaker’s honoraria from Servier, MLN,BN,JMR,EG,ES,BS,MG - Travel sponsorship from Fresenius Medical Care, BS - Travel sponsorship from Servier, MLN, PJ, BM, MA,KK,RK,KC - employees of Fresenius Nephrocare Dialysis Units, MB declares that he has no conflict of interest

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study contains retrospective observational data. For this type of study formal consent is not required. Protocol of the study received approval from the Local Bioethics Committee.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lichodziejewska-Niemierko, M., Chmielewski, M., Wojtaszek, E. et al. Current epidemiology and practice patterns in prevention and treatment of PD-related infections in Poland. Int Urol Nephrol 51, 335–341 (2019). https://doi.org/10.1007/s11255-018-2057-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-018-2057-9

Keywords

Search

Navigation